• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恩福林的 NMR 结构,一种新型的蛋白金属蛋白酶抑制剂:作用机制的见解。

NMR structure of emfourin, a novel protein metalloprotease inhibitor: Insights into the mechanism of action.

机构信息

Institute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia; National Research Centre "Kurchatov Institute", Moscow, Russia; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Institute of Molecular Genetics of National Research Centre "Kurchatov Institute", Moscow, Russia.

出版信息

J Biol Chem. 2023 Apr;299(4):104585. doi: 10.1016/j.jbc.2023.104585. Epub 2023 Mar 6.

DOI:10.1016/j.jbc.2023.104585
PMID:36889586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10124921/
Abstract

Emfourin (M4in) is a protein metalloprotease inhibitor recently discovered in the bacterium Serratia proteamaculans and the prototype of a new family of protein protease inhibitors with an unknown mechanism of action. Protealysin-like proteases (PLPs) of the thermolysin family are natural targets of emfourin-like inhibitors widespread in bacteria and known in archaea. The available data indicate the involvement of PLPs in interbacterial interaction as well as bacterial interaction with other organisms and likely in pathogenesis. Arguably, emfourin-like inhibitors participate in the regulation of bacterial pathogenesis by controlling PLP activity. Here, we determined the 3D structure of M4in using solution NMR spectroscopy. The obtained structure demonstrated no significant similarity to known protein structures. This structure was used to model the M4in-enzyme complex and the complex model was verified by small-angle X-ray scattering. Based on the model analysis, we propose a molecular mechanism for the inhibitor, which was confirmed by site-directed mutagenesis. We show that two spatially close flexible loop regions are critical for the inhibitor-protease interaction. One region includes aspartic acid forming a coordination bond with catalytic Zn of the enzyme and the second region carries hydrophobic amino acids interacting with protease substrate binding sites. Such an active site structure corresponds to the noncanonical inhibition mechanism. This is the first demonstration of such a mechanism for protein inhibitors of thermolysin family metalloproteases, which puts forward M4in as a new basis for the development of antibacterial agents relying on selective inhibition of prominent factors of bacterial pathogenesis belonging to this family.

摘要

Emfourin(M4in)是一种最近在细菌 Serratia proteamaculans 中发现的蛋白金属蛋白酶抑制剂,也是一个具有未知作用机制的新型蛋白蛋白酶抑制剂家族的原型。热稳定蛋白酶(thermolysin)家族的蛋白酶样蛋白酶(PLPs)是 emfourin 样抑制剂的天然靶标,这些抑制剂在细菌中广泛存在,在古菌中也有发现。现有数据表明,PLPs 参与了细菌之间以及细菌与其他生物体之间的相互作用,并可能与发病机制有关。可以说,emfourin 样抑制剂通过控制 PLP 活性参与了细菌发病机制的调节。在这里,我们使用溶液 NMR 光谱法测定了 M4in 的 3D 结构。得到的结构与已知的蛋白质结构没有明显的相似性。该结构被用于模拟 M4in-酶复合物,并用小角 X 射线散射对复合物模型进行了验证。基于模型分析,我们提出了抑制剂的分子机制,并通过定点突变得到了证实。我们表明,两个空间上接近的柔性环区对于抑制剂-蛋白酶相互作用至关重要。一个区域包含与酶的催化 Zn 形成配位键的天冬氨酸,另一个区域携带与蛋白酶底物结合位点相互作用的疏水性氨基酸。这种活性位点结构对应于非典型的抑制机制。这是首次证明热稳定蛋白酶家族金属蛋白酶的蛋白抑制剂具有这种机制,这为开发依赖于选择性抑制属于该家族的细菌发病机制中突出因素的抗菌剂提供了新的依据。

相似文献

1
NMR structure of emfourin, a novel protein metalloprotease inhibitor: Insights into the mechanism of action.恩福林的 NMR 结构,一种新型的蛋白金属蛋白酶抑制剂:作用机制的见解。
J Biol Chem. 2023 Apr;299(4):104585. doi: 10.1016/j.jbc.2023.104585. Epub 2023 Mar 6.
2
The protealysin operon encodes emfourin, a prototype of a novel family of protein metalloprotease inhibitors.蛋白酶操纵子编码 emfourin,这是一种新型蛋白金属蛋白酶抑制剂家族的原型。
Int J Biol Macromol. 2021 Feb 1;169:583-596. doi: 10.1016/j.ijbiomac.2020.12.170. Epub 2020 Dec 29.
3
NMR assignments and secondary structure distribution of emfourin, a novel proteinaceous protease inhibitor.新型蛋白质类蛋白酶抑制剂emfourin的核磁共振(NMR)归属及二级结构分布
Biomol NMR Assign. 2021 Jun 6. doi: 10.1007/s12104-021-10030-x.
4
An Internally Quenched Fluorescent Peptide Substrate for Protealysin.糜蛋白酶的一种内熄灭荧光肽底物。
Sci Rep. 2019 Oct 4;9(1):14352. doi: 10.1038/s41598-019-50764-2.
5
Protealysin is not Secreted Constitutively.蛋白酶不是组成型分泌的。
Protein Pept Lett. 2019;26(3):221-226. doi: 10.2174/0929866526666181212114907.
6
Processing of protealysin precursor.蛋白酶原的加工
Biochimie. 2009 May;91(5):639-45. doi: 10.1016/j.biochi.2009.03.008. Epub 2009 Mar 25.
7
Production and Characterization of Photorin, a Novel Proteinaceous Protease Inhibitor from the Entomopathogenic Bacteria Photorhabdus laumondii.光敏蛋白的生产与特性研究,一种来自昆虫病原细菌 Photorhabdus laumondii 的新型蛋白水解酶抑制剂。
Biochemistry (Mosc). 2023 Sep;88(9):1356-1367. doi: 10.1134/S0006297923090158.
8
Probing for actinase activity of protealysin.探究蛋白酶解酶的肌动蛋白酶活性。
Biochemistry (Mosc). 2009 Jun;74(6):648-54. doi: 10.1134/s0006297909060091.
9
Assay for Protealysin-like Protease Inhibitor Activity.蛋白酶样蛋白酶抑制剂活性测定。
Bio Protoc. 2022 Oct 5;12(19). doi: 10.21769/BioProtoc.4528.
10
Protealysin Targets the Bacterial Housekeeping Proteins FtsZ and RecA.蛋白酶靶向细菌管家蛋白 FtsZ 和 RecA。
Int J Mol Sci. 2022 Sep 15;23(18):10787. doi: 10.3390/ijms231810787.

本文引用的文献

1
Assay for Protealysin-like Protease Inhibitor Activity.蛋白酶样蛋白酶抑制剂活性测定。
Bio Protoc. 2022 Oct 5;12(19). doi: 10.21769/BioProtoc.4528.
2
An engineered protein-based submicromolar competitive inhibitor of the virulence factor aureolysin.一种基于工程蛋白的毒力因子金黄色葡萄球菌溶素的亚微摩尔级竞争性抑制剂。
Comput Struct Biotechnol J. 2022 Jan 6;20:534-544. doi: 10.1016/j.csbj.2022.01.001. eCollection 2022.
3
Neuroserpin: structure, function, physiology and pathology.神经丝氨酸蛋白酶抑制剂:结构、功能、生理学和病理学。
Cell Mol Life Sci. 2021 Oct;78(19-20):6409-6430. doi: 10.1007/s00018-021-03907-6. Epub 2021 Aug 17.
4
The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.丝氨酸蛋白酶抑制剂超家族及其在 COPD 和其他慢性肺部疾病中对丝氨酸蛋白酶活性的调节和功能障碍的作用。
Int J Mol Sci. 2021 Jun 14;22(12):6351. doi: 10.3390/ijms22126351.
5
NMR assignments and secondary structure distribution of emfourin, a novel proteinaceous protease inhibitor.新型蛋白质类蛋白酶抑制剂emfourin的核磁共振(NMR)归属及二级结构分布
Biomol NMR Assign. 2021 Jun 6. doi: 10.1007/s12104-021-10030-x.
6
Serpins in cartilage and osteoarthritis: what do we know?软骨与骨关节炎中的丝氨酸蛋白酶抑制剂:我们了解多少?
Biochem Soc Trans. 2021 Apr 30;49(2):1013-1026. doi: 10.1042/BST20201231.
7
: expanded functionality and new tools for small-angle scattering data analysis.用于小角散射数据分析的扩展功能和新工具。
J Appl Crystallogr. 2021 Feb 1;54(Pt 1):343-355. doi: 10.1107/S1600576720013412.
8
A Narrative Review on Plasminogen Activator Inhibitor-1 and Its (Patho)Physiological Role: To Target or Not to Target?纤溶酶原激活物抑制剂-1 的综述及其(病理)生理学作用:靶向还是不靶向?
Int J Mol Sci. 2021 Mar 8;22(5):2721. doi: 10.3390/ijms22052721.
9
Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.黏膜组织中的分泌型白细胞蛋白酶抑制剂(SLPI):既能抗炎,也能致癌。
Cytokine Growth Factor Rev. 2021 Jun;59:22-35. doi: 10.1016/j.cytogfr.2021.01.005. Epub 2021 Feb 10.
10
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.基质金属蛋白酶及其抑制剂在人类疾病中的作用。
Int J Mol Sci. 2020 Dec 20;21(24):9739. doi: 10.3390/ijms21249739.